BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 24141989)

  • 1. Cardioprotective effects of adipokine apelin on myocardial infarction.
    Zhang BH; Guo CX; Wang HX; Lu LQ; Wang YJ; Zhang LK; Du FH; Zeng XJ
    Heart Vessels; 2014 Sep; 29(5):679-89. PubMed ID: 24141989
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Post-infarct treatment with [Pyr(1)]apelin-13 improves myocardial function by increasing neovascularization and overexpression of angiogenic growth factors in rats.
    Azizi Y; Faghihi M; Imani A; Roghani M; Zekri A; Mobasheri MB; Rastgar T; Moghimian M
    Eur J Pharmacol; 2015 Aug; 761():101-8. PubMed ID: 25936512
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Apelin-13 increases myocardial progenitor cells and improves repair postmyocardial infarction.
    Li L; Zeng H; Chen JX
    Am J Physiol Heart Circ Physiol; 2012 Sep; 303(5):H605-18. PubMed ID: 22752632
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chinese medicine GeGen-DanShen extract protects from myocardial ischemic injury through promoting angiogenesis via up-regulation of VEGF/VEGFR2 signaling pathway.
    Zhai S; Zhang XF; Lu F; Chen WG; He X; Zhang CF; Wang CZ; Yuan CS
    J Ethnopharmacol; 2021 Mar; 267():113475. PubMed ID: 33068653
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of mini-tyrosyl-tRNA synthetase/mini-tryptophanyl-tRNA synthetase on ischemic angiogenesis in rats: proliferation and migration of endothelial cells.
    Zeng R; Chen YC; Zeng Z; Liu WQ; Jiang XF; Liu R; Qiang O; Li X
    Heart Vessels; 2011 Jan; 26(1):69-80. PubMed ID: 20963594
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Promoting effects of the adipokine, apelin, on diabetic nephropathy.
    Zhang BH; Wang W; Wang H; Yin J; Zeng XJ
    PLoS One; 2013; 8(4):e60457. PubMed ID: 23577111
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Apelin enhances cardiac neovascularization after myocardial infarction by recruiting aplnr+ circulating cells.
    Tempel D; de Boer M; van Deel ED; Haasdijk RA; Duncker DJ; Cheng C; Schulte-Merker S; Duckers HJ
    Circ Res; 2012 Aug; 111(5):585-98. PubMed ID: 22753078
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Loss of Apelin exacerbates myocardial infarction adverse remodeling and ischemia-reperfusion injury: therapeutic potential of synthetic Apelin analogues.
    Wang W; McKinnie SM; Patel VB; Haddad G; Wang Z; Zhabyeyev P; Das SK; Basu R; McLean B; Kandalam V; Penninger JM; Kassiri Z; Vederas JC; Murray AG; Oudit GY
    J Am Heart Assoc; 2013 Jul; 2(4):e000249. PubMed ID: 23817469
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intramyocardial delivery of VEGF165 via a novel biodegradable hydrogel induces angiogenesis and improves cardiac function after rat myocardial infarction.
    Zhu H; Jiang X; Li X; Hu M; Wan W; Wen Y; He Y; Zheng X
    Heart Vessels; 2016 Jun; 31(6):963-75. PubMed ID: 26142379
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of angiotensin-converting enzyme inhibition and bradykinin peptides in rats with myocardial infarction.
    Qu Z; Xu H; Tian Y
    Int J Clin Exp Pathol; 2015; 8(3):3410-7. PubMed ID: 26045879
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Erythropoietin stimulates normal endothelial progenitor cell-mediated endothelial turnover, but attributes to neovascularization only in the presence of local ischemia.
    Westenbrink BD; Oeseburg H; Kleijn L; van der Harst P; Belonje AM; Voors AA; Schoemaker RG; de Boer RA; van Veldhuisen DJ; van Gilst WH
    Cardiovasc Drugs Ther; 2008 Aug; 22(4):265-74. PubMed ID: 18327705
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sequential delivery of angiogenic growth factors improves revascularization and heart function after myocardial infarction.
    Awada HK; Johnson NR; Wang Y
    J Control Release; 2015 Jun; 207():7-17. PubMed ID: 25836592
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sepiapterin enhances angiogenesis and functional recovery in mice after myocardial infarction.
    Shimazu T; Otani H; Yoshioka K; Fujita M; Okazaki T; Iwasaka T
    Am J Physiol Heart Circ Physiol; 2011 Nov; 301(5):H2061-72. PubMed ID: 21890687
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of Intracoronary Infusion of Escalating Doses of Cardiac Stem Cells in Rats With Acute Myocardial Infarction.
    Tang XL; Rokosh G; Sanganalmath SK; Tokita Y; Keith MC; Shirk G; Stowers H; Hunt GN; Wu W; Dawn B; Bolli R
    Circ Heart Fail; 2015 Jul; 8(4):757-65. PubMed ID: 25995227
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Catalpol pretreatment attenuates cardiac dysfunction following myocardial infarction in rats.
    Bi F; Xu Y; Sun Q
    Anatol J Cardiol; 2018 May; 19(5):296-302. PubMed ID: 29724983
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human umbilical cord-derived endothelial progenitor cells promote growth cytokines-mediated neorevascularization in rat myocardial infarction.
    Hu CH; Li ZM; DU ZM; Zhang AX; Yang DY; Wu GF
    Chin Med J (Engl); 2009 Mar; 122(5):548-55. PubMed ID: 19323906
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Resveratrol ameliorates myocardial damage by inducing vascular endothelial growth factor-angiogenesis and tyrosine kinase receptor Flk-1.
    Fukuda S; Kaga S; Zhan L; Bagchi D; Das DK; Bertelli A; Maulik N
    Cell Biochem Biophys; 2006; 44(1):43-9. PubMed ID: 16456233
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Apelin-13 Protects against Ischemic Blood-Brain Barrier Damage through the Effects of Aquaporin-4.
    Chu H; Yang X; Huang C; Gao Z; Tang Y; Dong Q
    Cerebrovasc Dis; 2017; 44(1-2):10-25. PubMed ID: 28402976
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Soluble transforming growth factor-beta1 receptor II might inhibit transforming growth factor-beta-induced myofibroblast differentiation and improve ischemic cardiac function after myocardial infarction in rats.
    Lian R; Chen Y; Xu Z; Zhang X
    Coron Artery Dis; 2010 Sep; 21(6):369-77. PubMed ID: 20613497
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tissue-engineered pro-angiogenic fibroblast scaffold improves myocardial perfusion and function and limits ventricular remodeling after infarction.
    Fitzpatrick JR; Frederick JR; McCormick RC; Harris DA; Kim AY; Muenzer JR; Gambogi AJ; Liu JP; Paulson EC; Woo YJ
    J Thorac Cardiovasc Surg; 2010 Sep; 140(3):667-76. PubMed ID: 20363480
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.